$ACHV·4

ONCOGENEX PHARMACEUTICALS, INC. · Jan 12, 11:31 AM ET

ONCOGENEX PHARMACEUTICALS, INC. 4

4 · ONCOGENEX PHARMACEUTICALS, INC. · Filed Jan 12, 2017

Insider Transaction Report

Form 4
Period: 2017-01-10
Cormack Scott Daniel
DirectorPresident and CEO
Transactions
  • Exercise/Conversion

    Restricted Stock Unit (RSU)

    2017-01-106,2506,250 total
    Exp: 2018-04-13Common Stock (6,250 underlying)
  • Exercise/Conversion

    Restricted Stock Unit (RSU)

    2017-01-104,6870 total
    Exp: 2017-01-31Common Stock (4,687 underlying)
  • Exercise/Conversion

    Restricted Stock Unit (RSU)

    2017-01-109,37518,750 total
    Exp: 2019-06-18Common Stock (9,375 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2017-01-102,5000 total(indirect: By Spouse)
    Exp: 2017-01-31Common Stock (2,500 underlying)
  • Exercise/Conversion

    Common Stock

    2017-01-10+10,31284,055 total(indirect: By Spouse)
  • Exercise/Conversion

    Restricted Stock Unit (RSU)

    2017-10-103,1253,125 total(indirect: By Spouse)
    Exp: 2018-04-13Common Stock (3,125 underlying)
  • Exercise/Conversion

    Common Stock

    2017-01-10+20,312149,740 total
  • Tax Payment

    Common Stock

    2017-01-10$0.63/sh9,690$6,105140,050 total
  • Exercise/Conversion

    Restricted Stock Unit (RSU)

    2017-10-104,6879,375 total(indirect: By Spouse)
    Exp: 2019-06-18Common Stock (4,687 underlying)
Footnotes (6)
  • [F1]Represents shares of common stock acquired upon settlement of the restricted stock units ("RSUs") listed in Table II.
  • [F2]Represents shares of common stock that have been withheld by the issuer to satisfy the tax liability in connection with the settlement of RSUs.
  • [F3]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock at settlement.
  • [F4]Pursuant to the terms of the RSU, 25% of the total shares underlying the RSU vest annually on the later of (i) each anniversary of January 1, 2013; and (ii) the first day thereafter during which the issuer's trading window is open.
  • [F5]Pursuant to the terms of the RSU, 25% of the total shares underlying the RSU vest annually on the later of (i) each anniversary of January 1, 2014; and (ii) the first day thereafter during which the issuer's trading window is open.
  • [F6]Pursuant to the terms of the RSU, 25% of the total shares underlying the RSU vest annually on the later of (i) each anniversary of January 1, 2015; and (ii) the first day thereafter during which the issuer's trading window is open.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION